M1 macrophage infiltrations and histological changes in the liver after portal vein embolization using fibrinogen and OK432 in the rat

Cellular Immunology

Volumn 303, Issue , 2016, Pages 66-71

  Sato, Tetsu ^a   Marubashi, Shigeru ^a   Kenjo, Akira ^a   Tsuchiya, Takao ^a   Kimura, Takashi ^a   Sato, Naoya ^a   Watanabe, Junichiro ^a   Tasaki, Kazuhiro ^a   Hashimoto, Yuko ^a   Wada, Ikuo ^a   Gotoh, Mitsukazu ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Immune response; M1 macrophage; T helper 1 (Th1) cell

Indexed keywords

CD163 ANTIGEN; CD68 ANTIGEN; FIBRINOGEN; IODINATED POPPYSEED OIL; PICIBANIL; CD68 ANTIGEN, HUMAN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLIZATION; CELL INFILTRATION; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LIVER INJURY; MACROPHAGE; MALE; NONHUMAN; PORTAL VEIN; PORTAL VENOUS EMBOLIZATION; PRIORITY JOURNAL; RAT; TRANSARTERIAL IMMUNO EMBOLIZATION; ANIMAL; CELL MOTION; DRUG EFFECTS; IMMUNOLOGY; LIVER; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; SURGERY; WISTAR RAT;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL MOVEMENT; EMBOLIZATION, THERAPEUTIC; FIBRINOGEN; LIVER; LIVER NEOPLASMS; MACROPHAGES; MALE; PICIBANIL; PORTAL VEIN; RATS; RATS, WISTAR; RECEPTORS, CELL SURFACE;

EID: 84962385330     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2016.03.005     Document Type: Article

References (21)

1. Sieghart W., Hucke F., Peck-Radosavljevic M. Transarterial chemoembolization: modalities, indication, and patient selection. J. Hepatol. 2015, 62:1187-1195.
2. Katagiri S., Yamamoto M. Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus. Surg. Today 2014, 44:219-226.
3. Kanai T., Monden M., Sakon M., et al. New development of transarterial immunoembolization (TIE) for therapy of hepatocellular carcinoma with intrahepatic metastases. Cancer Chemother. Pharmacol. 1994, 33(Suppl):S48-S54.
4. Yoshida T., Sakon M., Umeshita K., et al. Appraisal of transarterial immunoembolization for hepatocellular carcinoma: a clinicopathologic study. J. Clin. Gastroenterol. 2001, 32:59-65.
5. Saito T., Tsuchiya T., Sato Y., et al. Effect of transarterial immunoembolization as preoperative treatment for hepatocellular carcinoma. Ann. Cancer Res. Ther 2011, 19:26-33.
6. Monden T., Morimoto H., Shimano T., et al. Use of fibrinogen to enhance the antitumor effect of OK-432. A new approach to immunotherapy for colorectal carcinoma. Cancer 1992, 69:636-642.
7. Takeda T., Kobayashi T., Monden T., et al. The effect of local immunotherapy for breast cancer using a mixture of OK-432 and fibrinogen supplemented with activated macrophages. Biotherapy 1993, 7:47-54.
8. Takeda T., Wakasugi T., Katsumoto Y., et al. Gan To Kagaku Ryoho 1992, 19:1458-1460.
9. Mantovani A., Sozzani S., Locati M., et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23:549-555.
10. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 2012, 122:787-795.
11. Ogasawara K., Uchino J., Une Y., Fujioka Y. Selective portal vein embolization with absolute ethanol induces hepatic hypertrophy and makes more extensive hepatectomy possible. Hepatology 1996, 23:338-345.
12. Furrer K., Tian Y., Pfammatter T., et al. Selective portal vein embolization and ligation trigger different regenerative responses in the rat liver. Hepatology 2008, 47:1615-1623.
13. Teger-Nilsson A.C., Blomback B. Rate of thrombin-fibrinogen reaction in some mammalian species. Thromb. Res. 1974, 5:223-233.
14. Ohishi H., Uchida H., Yoshimura H., et al. Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology 1985, 154:25-29.
15. Nakamura H., Hashimoto T., Oi H., Sawada S. Iodized oil in the portal vein after arterial embolization. Radiology 1988, 167:415-417.
16. Wang Y., Xiong B., Liang B., et al. Hepatic parenchymal changes following transcatheter embolization and chemoembolization in a rabbit tumor model. PLoS ONE 2013, 8:e70757.
17. Kan Z., Wallace S. Transcatheter liver lobar ablation: an experimental trial in an animal model. Eur. Radiol. 1997, 7:1071-1075.
18. Shi J., Fujieda H., Kokubo Y., Wake K. Apoptosis of neutrophils and their elimination by Kupffer cells in rat liver. Hepatology 1996, 24:1256-1263.
19. Janmey P.A., Winer J.P., Weisel J.W. Fibrin gels and their clinical and bioengineering applications. J. R. Soc. Interface 2009, 6:1-10.
20. Spicer P.P., Mikos A.G. Fibrin glue as a drug delivery system. J. Control. Release 2010, 148:49-55.
21. Barros M.H., Hauck F., Dreyer J.H., et al. Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages. PLoS ONE 2013, 8:e80908.